401 research outputs found
Monocytes, Dendritic Cells, Macrophages, T cells and Head and Neck Cancer : the effect of a thymic hormone preparation in restoring defective immune functions
It is generally accepted that cell mediated immunity (CMI) has more importance
in the control of cancer than the antibody-mediated immune response. The cell
mediated immune response is the basis of the so-called natural host resistance
to cancer, which is also referred to as "immunosurveillance". Although the
concept of immunosurveillance has been much debated over the past decades,
there is now no doubt that suppression of the immune function increases the
incidence of a few types of cancer. Also, spontaneous regression has been
observed for some tumors, including melanoma, renal cell carcinoma, and
lymphoma, and evidence for a role of immunosurveilance is well supported in
these tumors.
The role of a cell mediated immunosurveilance in patients with a head and neck
squamous cell carcinoma (HNSCC) is less clear. Immunosuppressed patients
do not develop head and neck cancer more frequently and spontanous
regression is at most anecdotal. Despite this, defects of the CMI in HNSCC
patients have extensively been documented. One of the first tests to reflect the
status of the CMI which was found abnormal in HNSCC patients, was delayed
type hypersensitivity (dth) as measured by skin reactions to ONCB-
dinitrochlorobenzene). Ninetyfive percent of the normal adult popUlation react
with a dth reaction towards skin-applied ONCB, however such a positive
reaction is often absent in HNSCC patients. These observations have not led
to a present clinical use of ONCB
Inhaled corticosteroids and growth of airway function in asthmatic children
Airway inflammation and remodelling play an important role in the
pathophysiology of asthma. Remodelling may affect childhood lung function,
and this process may be reversed by anti-inflammatory treatment. The
current study assessed longitudinally whether asthma affects growth of
airway function relative to airspaces, and if so whether this is redressed
by inhaled corticosteroids (ICS). Every 4 months for up to 3 yrs, lung
function was assessed in 54 asthmatic children (initial age 7-16 yrs), who
inhaled 0.2 mg salbutamol t.i.d. and 0.2 mg budesonide t.i.d.
(beta2-agonist (BA)+ICS), or placebo (PL) t.i.d. (BA+PL) in a randomised,
double-blind design. Measurements were carried out before and after
maximal bronchodilation. Airway growth was assessed from the change of
forced expiratory volume in one second and of maximal expiratory flows (at
60% and 40% of total lung capacity (TLC) remaining in the lung) relative
to TLC, as measures of more central, intermediate and more peripheral
airways. Growth patterns were compared with the longitudinal findings in
376 healthy children. Airway patency after maximal bronchodilation in
patients on BA+PL remained reduced compared to healthy subjects, whereas
in patients on BA+ICS a marked improvement was observed to subnormal. No
differences between patients and controls could be demonstrated for growth
patterns of central and intermediate airway function. Compliance with
BA+ICS was 75% of the prescribed dose, resulting in significant, sustained
improvement of symptoms and postbronchodilator calibre of central and
intermediate airways to subnormal within 2 months, but postbronchodilator
small airway patency remained reduced, though improved compared to
patients on BA+PL. Anti-inflammatory treatment of asthmatic children is
associated with normal functional development of central and intermediate
airways. The persistently reduced postbronchodilator patency of peripheral
airways may reflect remodelling, or insufficient anti-inflammatory
treatment
Airway responsiveness after a single dose of salmeterol and during four months of treatment in children with asthma
Background: Inhalation of a single dose of the long-acting β2- adrenoceptor agonist salmeterol protects against methacholine-induced airway obstruction and other bronchoconstricting stimuli for at least 12 hours. Hypothetically, twice daily dosing of salmeterol may result in continuous protection. Objective: this study was designed to investigate the protective effect of a single dose of salmeterol and of continuous twice daily treatment on airway responsiveness to methacholine. Methods: In a double-blind, parallel study, salmeterol 50 μg twice daily was compared with salbutamol 200 μg twice daily. Thirty children with mild asthma, who had little or no bronchial obstruction and were hyperresponsive to methacholine (PD20 ≤ 150 μg) were allocated to receive either salmeterol or salbutamol. Airway responsiveness was measured before study entry, 12 hours after a single dose of drug was given, and monthly during 4 months of daily treatment. Measurements were always performed at the same time of the day, 12 hours after the last dose of medication was administered. Results: No significant differences in FEV1 were found between treatments at any time point. PD20 significantly increased after the first dose of salmeterol was given (geometric mean, 100 μg). Geometric mean PD20 values were significantly better during salmeterol treatment than during salbutamol treatment, 52 and 25 μg, respectively (p = 0.005). Conclusion: The protection provided by salmeterol during maintenance treatment was less than that provided after the first dose (p < 0.001). However, protection did not diminish during the 4- month treatment period and remained significant compared with baseline (p = 0.003)
Prophylactic anti-staphylococcal antibiotics for cystic fibrosis
Background
Staphylococcus aureus causes pulmonary infection in young children with cystic fibrosis. Prophylactic antibiotics are prescribed hoping to prevent such infection and lung damage. Antibiotics have adverse effects and long-term use might lead to infection with Pseudomonas aeruginosa.
Objectives
To assess continuous oral antibiotic prophylaxis to prevent the acquisition of Staphylococcus aureus versus no prophylaxis in people with cystic fibrosis, we tested these hypotheses. Prophylaxis:
1. improves clinical status, lung function and survival;
2. causes adverse effects (e.g. diarrhoea, skin rash, candidiasis);
3. leads to fewer isolates of common pathogens from respiratory secretions;
4. leads to the emergence of antibiotic resistance and colonisation of the respiratory tract with Pseudomonas aeruginosa.
Search methods
We searched the Cochrane Cystic Fibrosis and Genetic Disorders Group Trials Register, comprising references identified from comprehensive electronic database searches, handsearches of relevant journals and abstract books of conference proceedings. Companies manufacturing anti-staphylococcal antibiotics were contacted.
Most recent search of Register: 04 September 2014.
Selection criteria
Randomised trials of continuous oral prophylactic antibiotics (given for at least one year) compared to intermittent antibiotics given ’as required’, in people with cystic fibrosis of any disease severity.
Data collection and analysis
The authors assessed studies for eligibility and methodological quality and extracted data.
Main results
We included four studies, totaling 401 randomised participants aged zero to seven years on enrolment. The two older studies generally had a higher risk of bias across all domains, but in particular due to a lack of blinding and incomplete outcome data, than the two more recent studies. We only regarded the most recent study as being generally free of bias, although even here we were not certain of the effect of the per protocol analysis on the study results. Fewer children receiving anti-staphylococcal antibiotic prophylaxis had one or more isolates of Staphylococcus aureus. There was no significant difference between groups in infant or conventional lung function. We found no significant effect on nutrition, hospital admissions, additional courses of antibiotics or adverse effects. There was no significant difference in the number of isolates of Pseudomonas aeruginosa between groups, though there was a trend towards a lower cumulative isolation rate of Pseudomonas aeruginosa in the prophylaxis group at two and three years and towards a higher rate from four to six years. As the studies reviewed lasted six years or less, conclusions cannot be drawn about the long-term effects of prophylaxis.
Authors’ conclusions
Anti-staphylococcal antibiotic prophylaxis leads to fewer children having isolates of Staphylococcus aureus, when commenced early in infancy and continued up to six years of age. The clinical importance of this finding is uncertain. Further research may establish whether the trend towards more children with CF with Pseudomonas aeruginosa, after four to six years of prophylaxis, is a chance finding and whether choice of antibiotic or duration of treatment might influence this
Early and long-term morbidity after total laryngopharyngectomy
To determine the early and long-term morbidity of patients treated with a total laryngopharyngectomy and reconstruction using a jejunum interposition or gastric pull-up procedure. It is a retrospective study; and it is conducted in tertiairy referral center. Sixty-three patients were included in whom 70 reconstructions were performed (51 jejunum interpositions and 19 gastric pull-up procedures) between 1990 and 2007. The studied parameters were success rate of the reconstruction, early and long-term complication rate, and functional outcome including quality of life. Subjective quality of life analysis was determined by two questionnaires: the EORTC Quality of Life Questionnaire (QLQ)-C30 Dutch version 3.0, and the EORTC-Head and Neck (H & N 35). The success rates were 84 and 74%, respectively. The procedures were associated with a high complication rate (63% after jejunum interposition and 89% after gastric pull-up), and a lengthy rehabilitation. Surviving patients were found to have a good long-term quality of life. Complete oral intake was achieved in 97%, and speech rehabilitation in 95%. These procedures are associated with significant morbidity, high complication rates, lengthy rehabilitation, but a good long-term quality of life
Importin-13 genetic variation is associated with improved airway responsiveness in childhood asthma
<p>Abstract</p> <p>Background</p> <p>Glucocorticoid function is dependent on efficient translocation of the glucocorticoid receptor (GR) from the cytoplasm to the nucleus of cells. Importin-13 (IPO13) is a nuclear transport receptor that mediates nuclear entry of GR. In airway epithelial cells, inhibition of IPO13 expression prevents nuclear entry of GR and abrogates anti-inflammatory effects of glucocorticoids. Impaired nuclear entry of GR has been documented in steroid-non-responsive asthmatics. We hypothesize that common IPO13 genetic variation influences the anti-inflammatory effects of inhaled corticosteroids for the treatment of asthma, as measured by change in methacholine airway hyperresponsiveness (AHR-PC<sub>20</sub>).</p> <p>Methods</p> <p>10 polymorphisms were evaluated in 654 children with mild-to-moderate asthma participating in the Childhood Asthma Management Program (CAMP), a clinical trial of inhaled anti-inflammatory medications (budesonide and nedocromil). Population-based association tests with repeated measures of PC<sub>20 </sub>were performed using mixed models and confirmed using family-based tests of association.</p> <p>Results</p> <p>Among participants randomized to placebo or nedocromil, IPO13 polymorphisms were associated with improved PC<sub>20 </sub>(i.e. less AHR), with subjects harboring minor alleles demonstrating an average 1.51–2.17 fold increase in mean PC<sub>20 </sub>at 8-months post-randomization that persisted over four years of observation (p = 0.01–0.005). This improvement was similar to that among children treated with long-term inhaled corticosteroids. There was no additional improvement in PC<sub>20 </sub>by IPO13 variants among children treated with inhaled corticosteroids.</p> <p>Conclusion</p> <p>IPO13 variation is associated with improved AHR in asthmatic children. The degree of this improvement is similar to that observed with long-term inhaled corticosteroid treatment, suggesting that IPO13 variation may improve nuclear bioavailability of endogenous glucocorticoids.</p
Chemoradiation for advanced hypopharyngeal carcinoma: a retrospective study on efficacy, morbidity and quality of life
Chemoradiation (CRT) is a valuable treatment option for advanced hypopharyngeal squamous cell cancer (HSCC). However, long-term toxicity and quality of life (QOL) is scarcely reported. Therefore, efficacy, acute and long-term toxic effects, and long-term QOL of CRT for advanced HSCC were evaluated,using retrospective study and post-treatment quality of life questionnaires. in a tertiary hospital setting. Analysis was performed of 73 patients that had been treated with CRT. Toxicity was rated using the CTCAE score list. QOL questionnaires EORTC QLQ-C30, QLQ-H&N35, and VHI were analyzed. The most common acute toxic effects were dysphagia and mucositis. Dysphagia and xerostomia remained problematic during long-term follow-up. After 3Â years, the disease-specific survival was 41%, local disease control was 71%, and regional disease control was 97%. The results indicated that CRT for advanced HSCC is associated with high locoregional control and disease-specific survival. However, significant acute and long-term toxic effects occur, and organ preservation appears not necessarily equivalent to preservation of function and better QOL
- …